Overview: Microfilaria Detection TestIntroduction: The Microfilaria Detection Test detects microfilariae to diagnose filariasis, causing swelling or fever. Following 2023 WHO guidelines, it uses microscopy for high specificity, supporting parasite screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in parasitology for patients with suspected filarial infections, such as lymphatic filariasis.
Other Names: Microfilaria Assay, Filariasis Microscopy Test.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic accuracy.
Historical Milestone: Microfilaria testing began in the 1900s with parasitology research. Microscopy techniques improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects microfilariae to diagnose filariasis, guides treatment, and evaluates patients with swelling or fever.
Test Parameters: 1. Microfilariae
Pretest Condition: No fasting required. Collect whole blood or peripheral blood smear. Report history of swelling, fever, or travel to endemic areas.
Specimen: Whole Blood (EDTA, 2-5 mL), Peripheral Blood Smear (slide, 1-2 slides). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document swelling, fever, lymphedema, or travel history to filariasis-endemic areas. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, filariasis implications, and risks of blood collection.
Procedural Considerations: Uses microscopy to detect microfilariae in blood or smears. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for filariasis diagnosis.
Factors Affecting Result Accuracy: Improper slide preparation or low parasite load can affect results. Timing of blood collection impacts sensitivity.
Clinical Significance: Positive microfilariae detection confirms filariasis, guiding antiparasitic therapy (e.g., diethylcarbamazine). Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Filarial antigen test, PCR, or ultrasound to confirm filariasis diagnosis.
Test Limitations: Sensitivity depends on parasite load and collection timing; clinical correlation is needed.
References: WHO Filariasis Guidelines, 2023; The Lancet Infectious Diseases, Taylor MJ, 2022.
